Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix.

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Consumers are becoming more concerned about their health, with many prioritising weight loss. But what do they consider to be ...

The Therapeutic Goods Administration (TGA) has facilitated the seizure of millions of counterfeit and illegal therapeutic goods as part of INTERPOL's ...

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

NEW DELHI – India is witnessing a sharp rise in the demand for obesity and diabetes medications, with urban populations ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Georgia Tech engineers have created a pill that could effectively deliver insulin and other injectable drugs, making ...